Bioventus (BVS) Net Cash Flow (QoQ) (2020 - 2026)
Bioventus (BVS) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Bioventus | 975.28 Mn | 945.82 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 59.29% |
| Mar 28, 2026 | -265.35% |
| Dec 31, 2025 | -7.33% |
| Sep 27, 2025 | -2.60% |
| Jun 28, 2025 | 151.57% |
| Mar 29, 2025 | -3,464.27% |
| Dec 31, 2024 | -94.62% |
| Sep 28, 2024 | 46.60% |
| Jun 29, 2024 | 164.37% |
| Mar 30, 2024 | -215.13% |
| Dec 31, 2023 | 327.66% |
| Sep 30, 2023 | 33.44% |
| Jul 1, 2023 | -137.98% |
| Apr 1, 2023 | 480.90% |
| Dec 31, 2022 | 19.30% |
| Oct 1, 2022 | 86.67% |
| Jul 2, 2022 | -151.28% |
| Apr 2, 2022 | 48.24% |
| Dec 31, 2021 | -358.65% |
| Oct 2, 2021 | -181.10% |